Showing results (71-80 of 138) with videos related to
Sort By:
Pageof 14
Journal for Immunotherapy of Cancer|May 31, 2024
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?Hongbin Wang, Mia Borlongan, Howard L Kaufman, et al.Virologie (Montrouge, France)|January 9, 2020
Les vecteurs AAV pour le transfert de gène in vivo ou comment un petit virus devient grandRachel Millet, Axel Rossi, Aurélie Ploquin, et al.Journal of Virology|June 15, 2004
Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1Patrick Lomonte, Joëlle Thomas, Pascale Texier, et al.The Journal of General Virology|June 12, 2009
Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblastsEliza Tsitoura, Joëlle Thomas, Delphine Cuchet, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2011
Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenograftsTooba A Cheema, Ryuichi Kanai, Geon Woo Kim, et al.Human Gene Therapy|August 14, 2023
Viral Vectors Expressing Interleukin 2 for Cancer ImmunotherapyHongbin Wang, Mia Borlongan, Akseli Hemminki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Combination immunotherapy for tumors via sequential intratumoral injections of oncolytic herpes simplex virus 1 and immature dendritic cellsChristopher J Farrell, Cecile Zaupa, Zachary Barnard, et al.Journal of Molecular and Cellular Cardiology|December 30, 2004
Efficient and non-toxic gene transfer to cardiomyocytes using novel generation amplicon vectors derived from HSV-1René Ferrera, Delphine Cuchet, Cécile Zaupa, et al.Journal of Virology|March 7, 2008
Nucleolin is required for an efficient herpes simplex virus type 1 infectionAleth Callé, Iva Ugrinova, Alberto L Epstein, et al.Virus Genes|June 13, 2008
Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectorsSabine Schenck, Elke Kehm, Alberto L Epstein, et al.Pageof 14